patient with malignant intracranial hypertention.
Conditions
Interventions
Intervention 1: Intervention group: patient who had malignant intracranial hypertention and not releived with medical managment randomely devided to two group . On hinge cranioplasty patient underwent
Sponsors
Tehran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: patient with diagnosis of malignant intracranial hypertension indicate cerebral decompression despite medical management hemorrhagic and ischemic infarct of internal carotid territory patient with diagnosis of unilateral internal carotid territory intracranial hematoma that indicate surgery without coincidence hematoma E.g Subdural hematoma patient with traumatic unilateral temporal, parietal, frontal subdural hematoma or combination of them in one side even with same side contusion(not need evacuation) with intracranial pressure above 20cmHg or protrusion of brain parenchym out of site of craniectomy
Exclusion criteria
Exclusion criteria: pregnant women patient died during first day after operation occipital or cerebellar infarction (non internal carotid territory) patient with history of psychosis concomitant lesion e.g Brain tumor concomitant cerebrovascular lesion e.g aneurysm patient without follow up patient with history of neurological disorder that cause neurological deficit multiple cerebrovascular accident or multiple hemorrhagic lesion history of previous cerebrovascular accident bilateral cerebrovascular accident or bilateral hemorrhage concomitant subdural hematoma and intracranial hemorrhage traumatic posterior fossa hematoma intraventricular hemorrhage patient with subdural hematoma and glascow coma scale 3 without brain palsation depressed fracture and patient with dis-usable bone flap patient who underwent temporal lobectomy traumatic injury to thoracic, abdomen, pelvic and their content that need intervention
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Short term and long term evaluation of effect of hinge cranioplasty in decreasing intracranial pressure. Timepoint: 5 day - 3 month - 6 month - 1year. Method of measurement: ICP monitoring with subdural catheter in first 5 day - evaluating the patient with Modified Rankin scale and Glasgow Outcome scale in 3 and 6 month and 1year. | — |
Secondary
| Measure | Time frame |
|---|---|
| Long term quality of life and complication. Timepoint: 3 month - 6 month -1 year. Method of measurement: Modified Rankin scale and Glasgow Outcome scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMohammad Mostafa Harifi
Tehran University of Medical Sciences
Outcome results
None listed